Previous deletion analysis of the 5-flanking region of human GnRH receptor (GnRHR) gene has revealed a powerful negative regulatory element (NRE) located between nucleotide ؊1017 and ؊771. In the present study, we demonstrated that this NRE could repress the homologous promoter, irrespective of its position and completely abolish the activity of a heterologous thymidine kinase promoter in an orientationdependent manner. Progressive 3-deletion analysis revealed that most of the silencing activity of the NRE resided in a putative octamer regulatory sequence (5AAGCAAACT3), which alone could repress the promoter activities by 69 -90% in ovarian OVCAR-3, placental JEG-3, and gonadotropederived ␣T3-1 cells. Mutation of the AAAC residues of the octamer sequence completely removed its silencing activity. Interestingly, conversion of the octamer sequence into that of the rodent GnRHR promoter (5AAGCAAAGT3) did not attenuate its silencing effect, indicating that the repressive role of the octamer sequence is evolutionarily conserved. EMSAs showed that common DNA-protein complexes of the same mobility were formed with nuclear extracts from the reproductive cells and gonadotropes, and a consensus octamer transcription factor-1 (Oct-1) binding sequence could dose dependently inhibit the complex formation. Antibody supershift and Southwestern blot assays confirmed that the protein binding to the octamer sequence was the ubiquitously expressed transcription factor Oct- 
G nRH IS A DECAPEPTIDE that plays a pivotal role in
mammalian reproduction by stimulating the synthesis and secretion of gonadotropins via binding to the GnRH receptors (GnRHRs) on the pituitary gonadotropes. However, GnRH and its receptor mRNA transcripts have also been detected in some extrapituitary tissues including the ovary and placenta (1) (2) (3) , and there is increasing evidence that GnRH may act as an autocrine and paracrine factor in regulating local cellular functions in these organs (3) (4) (5) . Recent studies on the transcriptional regulation of human GnRHR gene have provided us some insights on the molecular mechanisms that mediate tissue-specific expression of the GnRHR gene. Our previous studies showed that the interaction between steroidogenic factor-1 and a downstream gonadotrope-specific element located within the first exon was responsible for the gonadotrope-specific expression of the GnRHR gene (6) . On the contrary, we recently found that an upstream promoter located between nucleotide (nt) Ϫ1737 and Ϫ1346 (relative to the ATG initiation codon) was found to be used specifically by the placental cells, and a cAMP-responsive element and a GATA motif were responsible for the placenta-specific expression of the GnRHR gene (7) . More recently we have characterized a novel upstream promoter for the GnRHR gene in the ovarian granulosa-lutein cells in which two putative CCAAT/ enhancer binding protein (C/EBP) and one putative GATA motifs function synergistically to regulate the GnRHR gene transcription (8) . Taken together, these findings suggest that tissue-specific expression of the human GnRHR gene is mediated, at least in part, by differential usage of various promoters in different cell types.
Apart from positive regulation by transcriptional activators, gene transcription may also be negatively controlled by silencer elements and their associated repressor proteins. Although an earlier study showed that there was an interplay between the pituitary adenylate cyclase-activating polypeptide (PACAP) and a silencer element located between nt Ϫ1676 and Ϫ1648 to regulate the activity of human GnRHR promoter in pituitary ␣T3-1 cells (9), the transcriptional repression of the human GnRHR gene remains poorly understood. Interestingly, previous deletion analysis of the human GnRHR 5Ј-flanking region has revealed a very powerful negative regulatory element (NRE) located between nt Ϫ1017 and Ϫ771. This NRE can completely suppress the basal activities of the homologous promoter in pituitary ␣T3-1 cells (10), ovarian carcinoma OVCAR-3 cells (10), placental JEG-3 cells (7) , and immortalized granulosa-lutein cells (8) , suggesting that the transcription factor(s) interacting with this element is ubiquitously expressed. However, the functional significance of this NRE remains unknown. In the present study, we demonstrated that this element could function as an orientation-dependent silencer in these cells and showed that Oct-1 was a transcriptional repressor of the GnRHR promoter and might play a very crucial role in silencing the GnRHR gene transcription.
Materials and Methods

Cells and cell culture
Immortalized human granulosa-lutein cells (SVOG-4o and SVOG4m) were generated with simian virus (SV) 40 large T antigen as previously reported (11) . Immortalized human ovarian surface epithelial cells (IOSE-29EC) (12) were provided by Dr. N. Auersperg (Department of Obstetrics and Gynecology, University of British Columbia, Vancouver, British Columbia, Canada). Human choriocarcinoma JEG-3 cells, ovarian carcinoma OVCAR-3 cells and human embryonic kidney HEK-293 cells were obtained from American Type Culture Collection (Manassas, VA). Mouse pituitary gonadotrope-derived ␣T3-1 cells were provided by Dr. P. L. Mellon (Department of Reproductive Medicine, University of California, San Diego, CA). The SVOG-4o, SVOG-4m, IOSE-29EC, and OVCAR-3 cells were maintained in M199/MCDB105 (1:1) supplemented with 10% fetal bovine serum (FBS) (Hyclone Laboratories, Inc., Logan, UT). The JEG-3, HEK-293, and ␣T3-1 cells were maintained in DMEM (Life Technologies, Inc., Burlington, Ontario, Canada) containing 10% FBS. Cultures were maintained at 37 C in humidified atmosphere with 5% CO 2 in air, and medium was renewed every 3 d. Cells were passaged using trypsin/EDTA solution (0.05% trypsin and 0.53 mm EDTA) or harvested for protein extraction when they reached about 80% confluence.
Plasmid construction and site-directed mutagenesis
The NRE (located between nt Ϫ1017 and Ϫ771 of human GnRHR 5Ј-flanking region) was amplified by PCR using primers containing a BamHI site (Table 1 ). The fragment was cloned into the BamHI site of pTK-Luc (kindly provided by Dr. V. Giguere, Molecular Oncology Group, McGill University Health Center, Montréal, Québec, Canada) and p(Ϫ1300/Ϫ1018)-Luc in both orientations. The p(Ϫ1300/Ϫ1018)-Luc contains a minimal human GnRHR promoter (from nt Ϫ1300 to Ϫ1018) cloned upstream of a luciferase reporter gene in the promoterless pGL2-Basic vector (Promega Corp., Nepean, Canada). Deletion constructs for fine mapping of the NRE were generated by PCR amplification of the corresponding regions of the human GnRHR 5Ј-flanking region, followed by subsequent cloning into the pGL2-Basic vector. The PCR was carried out for 30 cycles with denaturation for 30 sec at 94 C, annealing for 1 min at 60 C, extension for 1 min at 72 C, and a final extension for 15 min at 72 C. Restriction site (KpnI or HindIII) was artificially introduced into the primers (Table 1) . For site-directed mutagenesis, four octamer sequence variants were generated by PCR amplification using a forward primer p1300 and reverse primers containing the desired mutations (Table 1) . Mutations were confirmed by DNA sequence analysis. Oct-1 expression plasmid (pcDNA3-HA-Oct-1) and control plasmid (pcDNA3-HA) were provided by Dr. H. Singh (Howard Hughes Medical Institute, University of Chicago, Chicago, IL). Plasmid DNA for transient transfection was prepared using plasmid midi kits (QIAGEN, Chatsworth, CA) following the manufacturer's suggested procedures. The concentration and quality of DNA were determined by measuring absorbance at 260 nm and by agarose gel electrophoresis, respectively.
Transient transfection and reporter gene assay
Transient transfections were carried out using Lipofectamine reagent (Life Technologies, Inc.) following the manufacturer's suggested procedures. To correct for different transfection efficiencies of various luciferase constructs, the Rous sarcoma virus (RSV)-lacZ vector was cotransfected into cells with the GnRHR promoter-luciferase construct. Briefly, 4 ϫ 10 5 of cells were seeded into six-well tissue culture plates before the day of transfection. One microgram of the luciferase constructs and 1 g RSV-lacZ vector were cotransfected into the cells under serum-free conditions. For Oct-1 overexpression study, 1 g p(Ϫ1300/ Ϫ1009)-Luc, 1 g RSV-lacZ and 1 g pcDNA3-HA-Oct-1 (or control plasmid pcDNA3-HA) were cotransfected into the cells. After 5 h of transfection, 1 ml medium containing 20% FBS was added, and the cells were further incubated overnight (18 h). After incubation, the old medium was removed and the cells were cultured for another 24 h in a normal fresh medium containing 10% FBS before harvest. Cellular lysates were collected with 150 l reporter lysis buffer (Promega Corp.) and assayed for luciferase activity with the luciferase assay system (Promega Corp.). Luminescence was measured using a Lumat LB 9507 luminometer (EG&G, Berthold, Germany). ␤-Galactosidase activity was measured using the ␤-galactosidase enzyme assay system (Promega Corp.) and used to normalize transfection efficiencies. Promoter activity was calculated as luciferase activity/␤-galactosidase activity.
EMSAs
Overlapping oligonucleotides (Table 1) corresponding to the putative octamer sequence were synthesized by the Oligonucleotide Synthesis Laboratory (University of British Columbia) and annealed to form double-stranded DNA. Consensus Oct-1 (Oct-1-c), activating protein-2 (AP-2-c), nuclear factor-B (NF-B-c), and transcription factor IID (TFIID-c) oligonucleotides were purchased from Promega Corp. Probe for EMSA was end radiolabeled with [ 32 P]-ATP by T4 polynucleotide kinase (Life Technologies, Inc.) and separated from unincorporated radionucleotides by the Microspin G-25 columns (Amersham Pharmacia Biotech, Morgan, Canada). Nuclear extracts were prepared from OVCAR-3, JEG-3, and ␣T3-1 cells according to the method described previously (8) . Protein concentrations were determined by a modified Bradford assay (Bio-Rad Laboratories, Inc., Hercules, CA). EMSAs were carried out in 20 l containing 20 mm HEPES (pH 7.5), 50 mm NaCl, 1.5 mm MgCl 2 , 1 mm dithiothreitol, 1 mm EDTA, 10% glycerol, 1 g poly Restriction enzyme recognition sites introduced into some oligonucleotides are shown in italic, and the regions of mutated sequences are underlined.
(dI:dC), 2-10 g nuclear extracts, and 50 fmol radiolabeled probe (30,000 cpm). For the competitive assays, the competitor oligonucleotides were added simultaneously with the labeled probe. For antibody supershift assays, nuclear extracts were preincubated with either anti-Oct-1 (sc-232x) or anti-GATA-4 antibody (sc-1237x) (Santa Cruz Biotechnology, Inc., Santa Cruz, CA) at room temperature for 30 min before the addition of the radiolabeled probe. The binding reaction was incubated at room temperature for 15 min and separated on a 6% polyacrylamide gel containing 1ϫ 0.09 m Tris-borate and 2 mm EDTA (pH 8.0). Before loading of samples, the gel was prerun for 90 min at 100 V at 4 C. Electrophoresis was carried out at 30 mA at 4 C. The gel was then dried and exposed to x-ray film (Eastman Kodak Co., Rochester, NY) at Ϫ70 C.
Southwestern and Western blot analyses
Southwestern blot was performed essentially as previously described (13) . Crude nuclear extracts from OVCAR-3, JEG-3, and ␣T3-1 cells (100 g and 20 g proteins for Southwestern and Western blot analyses, respectively) were separated in duplicate lanes by sodium dodecyl sulfate-10% polyacrylamide gel and transferred to a nitrocellulose membrane (Hybond-C, Amersham Pharmacia Biotech). For Southwestern blot analysis, proteins were allowed to renature in TNED buffer [10 mm Tris (pH 7.5), 50 mm NaCl, 0.1 mm EDTA (pH 7.5), and 1 mm dithiothreitol] containing 5% milk overnight at room temperature. Afterward the membrane was rinsed three times in the TNED buffer, and incubated with 11 ml of the same buffer containing 75 pmol of the 32 P-radiolabeled probe used in the EMSA studies at room temperature overnight. After hybridization, the membrane was washed three times (10 min each) with the TNED buffer, dried, and subjected to autoradiography. For Western blot analysis, the membrane was blocked with 5% (wt/vol) nonfat dried milk in Tris-buffered saline containing 20 mm Tris-Cl (pH 8.0), 140 mm NaCl, and 0.05% (vol/vol) Tween-20 for 3 h at room temperature before incubating with the anti-Oct-1 antibody (1:10,000) (sc-232x, Santa Cruz Biotechnology, Inc.) overnight at 4 C. Immunostained proteins were visualized using an enhanced chemiluminescence system (Amersham Pharmacia Biotech).
Data analysis
For all transfection assays, data were shown as the mean Ϯ sem of triplicate assays in at least three independent experiments. For the Oct-1 overexpression study, data were analyzed by one-way ANOVA, followed by Tukey's multiple comparison test using the computer software PRISM (GraphPad Software, Inc., San Diego, CA). Data were considered significantly different from each other at P Ͻ 0.05. For EMSA and Southwestern blot analysis, all experiments were performed at least three times.
Results
Silencing effect of the NRE on a heterologous thymidine kinase (TK) promoter
To examine the ability of the NRE to repress a heterologous promoter, the NRE was placed immediately upstream of a TK promoter in the pTK-Luc vector in both orientations, and the constructs were transiently transfected into SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells (Fig. 1A) . The activities of the TK promoter were found to be completely abolished in these cell lines when the NRE was cloned in a sense orientation (sNRE-pTK-Luc). However, no significant changes of promoter activities (relative to the pTK-Luc) were observed when it was cloned in the opposite orientation (rNRE-pTKLuc), indicating that the NRE can function as an orientation-
Silencing activity of the NRE on a heterologous TK promoter. The NRE (shown as a shaded box) was placed immediately upstream of a TK promoter in pTK-Luc in both orientations (sNREpTK-Luc and rNRE-pTK-Luc) and the constructs were cotransfected with RSV-lacZ vector into various cell lines. A, The sNRE-pTK-Luc and rNRE-pTKLuc were analyzed in SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells. B, The sNRE-pTK-Luc was further analyzed in three additional cell lines, including SVOG-4o, IOSE-29EC, and HEK-293 cells. The relative promoter activity was represented as the percentage of the pTK-Luc whose activity was set as 100% after being normalized by ␤-galactosidase activity. Values represent the mean Ϯ SEM of three independent experiments each performed in triplicate.
dependent silencer. The construct sNRE-pTK-Luc was further analyzed in SVOG-4o, IOSE-29EC, and HEK-293 cells to demonstrate its silencing activity in other cell types. Similarly, the activities of the TK promoter were completely removed in these cells (Fig. 1B) .
Positional effect of the NRE silencing activity on the homologous promoter
To examine the positional effect of the NRE silencing activity, the NRE was subcloned into the BamHI site of the p(Ϫ1300/Ϫ1018)-Luc such that the NRE is situated at 2.8 kb upstream of a minimal human GnRHR promoter (nt Ϫ1300 to Ϫ1018). The activities of the minimal GnRHR promoter were reduced by about 65% in both SVOG-4m and ␣T3-1 cells, whereas approximately 57% reduction of promoter activities were detected in OVCAR-3 and JEG-3 cells when the NRE was cloned in a sense orientation (sNRE-p(Ϫ1300/ Ϫ1018)-Luc). In contrast, only about 28% reduction of promoter activities was observed when the NRE was cloned in the opposite orientation (rNRE-p(Ϫ1300/Ϫ1018)-Luc) (Fig.  2) . These results indicate that the NRE can function in a position-independent manner, but the repressive effect is weaker when the NRE is located further apart from the homologous promoter.
Identification of the critical nucleotide sequence(s) mediating the silencing effect of the NRE
Progressive 3Ј-deletion analysis was performed from nt Ϫ771 to Ϫ1017 to identify the nucleotide sequence(s) that constitutes the silencing activity of the NRE. Deletion constructs were analyzed in SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells and similar promoter activity profiles were observed in these cell lines (Fig. 3) . 3Ј-Deletion from nt Ϫ771 to Ϫ954 did not eliminate the silencing activity of the NRE, indicating that the core-repressive activity of the NRE resides in the distal 64-bp region (i.e. from nt Ϫ1017 to Ϫ954). To delineate the nucleotide sequence required for the silencing activity of the NRE, a more detailed 3Ј-deletion mapping was performed. Deletion from nt Ϫ954 to Ϫ1009 did not significantly increase the promoter activities in the reproductive cells and gonadotropes, and a putative octamer regulatory sequence (5ЈAAGCAAACT3Ј, nt Ϫ1017 to Ϫ1009) alone could reduce the activities of the homologous promoter by 76%, 78%, 90%, and 69% in SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells, respectively ( Fig. 4 ; the activities of p(Ϫ1300/ Ϫ1009)-Luc were 4434 RLU, 65253 RLU, 5336 RLU, and 16110 RLU in SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells, respectively). This observation clearly indicates that most of the silencing activity of the NRE retain in this octamer sequence.
To examine the functional significance of this octamer sequence, four site-directed mutants were generated and analyzed in the OVCAR-3, JEG-3, and ␣T3-1 cells. Mutation of the sequence AAGC to TGTG within the putative octamer motif restored the promoter activities by 64%, 48%, and 74% in OVCAR-3, JEG-3, and ␣T3-1 cells, respectively. However, mutation of the sequence AAAC to TGTG completely resumed the promoter activities in OVCAR-3 and ␣T3-1 cells, and 80% recovery of promoter activity was observed in the JEG-3 cells (Fig. 5) . Alteration of the octamer sequence into the consensus Oct-1 binding motif (5ЈATGCAAAT3Ј) alleviated its silencing activity in all the three cell lines. Interestingly, a single-point mutation (AAAC to AAAG) converting the octamer sequence into that of the rodent GnRHR promoter did not attenuate its silencing activity, suggesting that the repressive role of the octamer sequence is evolutionarily conserved.
Binding of the POU domain transcription factor Oct-1 to the putative octamer regulatory sequence
Because the octamer sequence can repress the GnRHR promoter in OVCAR-3, JEG-3, and ␣T3-1 cells, we sought to examine whether the same transcription factor from these cell lines binds to this putative octamer sequence. To address this question, EMSA studies using various amounts of nuclear extracts from OVCAR-3, JEG-3, and ␣T3-1 cells were performed. Common DNA-protein complexes of the same mobility (complex-A) were formed in a dose-dependent manner when nuclear extracts from these cells were used. However, the intensity of complex-A was much weaker, and an additional DNA-protein complex (complex-B) was ob-
Positional effect of the NRE silencing activity on the homologous promoter. The NRE (shown as a shaded box) was subcloned in both orientations, into the BamHI site of p(Ϫ1300/ Ϫ1018)-Luc, which contains a minimal human GnRHR promoter (nt Ϫ1300 to Ϫ1018) in pGL2-Basic vector, and the constructs were designated as sNREp(Ϫ1300/Ϫ1018)-Luc and rNRE-p(Ϫ1300/ Ϫ1018)-Luc, respectively. The luciferase constructs were transiently transfected into SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells. The relative promoter activity was represented as the percentage of the p(Ϫ1300/Ϫ1018)-Luc whose activity was set as 100% after being normalized by ␤-galactosidase activity. Values represent the mean Ϯ SEM of three independent experiments each performed in triplicate. served with nuclear extracts from ␣T3-1 cells (Fig. 6A ). Competitive EMSA studies showed that the formation of these complexes could be inhibited by the unlabeled probe (100-to 500-fold excess) but not by other sequences including NF-B-c, AP-2-c and TFIID-c (500-fold excess; Fig. 6B ). These observations indicate that the formation of these complexes is specific to the octamer sequence. Interestingly, an oligonucleotide containing the consensus Oct-1 binding motif was found to inhibit the formation of complex-A in a dosedependent manner (Fig. 6C) . Addition of anti-Oct-1 but not anti-GATA-4 antibody in the supershift assays prevented complex-A formation specifically (Fig. 6D) . Western blot analysis of nuclear extracts from OVCAR-3, JEG-3, and ␣T3-1 cells revealed that the endogenous expression levels of Oct-1 protein were much lower in the gonadotropes (Fig. 7A) , and this observation was in agreement with the weaker Oct-1-binding signal detected in both Southwestern blot (Fig. 7B ) and EMSA studies (Fig. 6A, complex-A formation) . Taken together, these results clearly indicate that the POU domain transcription factor Oct-1 binds to the putative octamer sequence of the human GnRHR promoter.
To further assess the functional significance of Oct-1 in the transcriptional repression of the human GnRHR promoter, an Oct-1 expression plasmid was cotransfected with p(Ϫ1300/Ϫ1009)-Luc into OVCAR-3, JEG-3, and ␣T3-1 cells (Fig. 8) . Although overexpression of Oct-1 in the ovarian and placental cells did not augment the silencing activity of the octamer sequence, a further 31% reduction (P Ͻ 0.05 vs. control) of the GnRHR promoter activity was observed in the gonadotropes. The lack of response to Oct-1 overexpression in the reproductive cells may be due to their high endogenous levels of Oct-1 proteins (Fig. 7A) . Nevertheless, these results confirm the role of Oct-1 as a repressor on the GnRHR promoter.
Discussion
Recent studies on the transcriptional regulation of human GnRHR gene in the gonadotropes (6) , placenta (7), and ovarian granulosa-lutein cells (8) suggest that tissue-specific expression of the GnRHR gene is mediated by differential usage of promoters in various cell types. However, the transcriptional repression of the GnRHR gene in human or Four mutants (Mut-a, Mut-b, Mut-cOct-1, and Mut-rOct-1) were constructed by PCR using forward primer p1300 and reverse primers containing the desired mutations. The AAGC residues of the putative octamer sequence were mutated to TGTG in Mut-a, whereas the AAAC residues were mutated to TGTG in Mut-b. The octamer sequence was mutated to a consensus Oct-1 binding motif and that of the rodent GnRHR promoter in Mut-cOct-1 and Mut-rOct-1, respectively. The promoter constructs were transiently transfected into OVCAR-3, JEG-3, and ␣T3-1 cells. The relative promoter activity was represented as the percentage of the p(Ϫ1300/Ϫ1018)-Luc whose activity was set as 100% after being normalized by ␤-galactosidase activity. Values represent the mean Ϯ SEM of three independent experiments each performed in triplicate.
FIG. 6. EMSAs to characterize the putative octamer binding sequence using nuclear extracts (NEs) from different cell lines. Synthetic oligonucleotides containing the putative octamer sequence was annealed to form a double-strand DNA, and the probe was end radiolabeled with 32 P and incubated with NEs from OVCAR-3, JEG-3, and ␣T3-1 cells in the absence or presence of competitor oligonucleotides (or antibodies). A, Formation of DNA-protein complexes with increasing amount (2-15 g) of NEs from OVCAR-3, JEG-3, and ␣T3-1 cells in the presence of 50 fmol the radiolabeled probe containing the putative octamer sequence. B, NEs from OVCAR-3 (2 g), JEG-3 (2 g), and ␣T3-1 (10 g) cells were incubated with 50 fmol the radiolabeled probe in the presence of an increasing amount of cold competitor (100-to 500-fold excess) or 500-fold excess of NF-B-c, AP-2-c, or TFIID-c oligonucleotide. C, NEs from OVCAR-3 (2 g), JEG-3 (2 g), and ␣T3-1 (10 g) cells were incubated with 50 fmol the radiolabeled probe in the presence of increasing amount of a consensus Oct-1 binding sequence (100-to 500-fold excess). D, Two micrograms and 10 g of NEs from JEG-3 cells and ␣T3-1 cells were preincubated with 4 g anti-Oct-1 or anti-GATA-4 antibody for 30 min at room temperature before addition of the radiolabeled probe.
other species remains poorly understood. A previous study has revealed that there was a putative repressor element (nt Ϫ343 to Ϫ335) within the mouse GnRHR promoter, and deletion of this element could significantly increase the promoter activities in both basal and GnRH-agonist-, phorbol ester-, and forskolin-stimulated GGH3 cells (14) . Recently Ngan et al. (9) showed that that there was an interplay between PACAP and an upstream silencer element within the human GnRHR promoter in the pituitary ␣T3-1 cells, and the PACAP-responsive element was mapped to nt Ϫ1674/ Ϫ1648 by scanning mutation analysis. However, none of these reports could identify the repressor proteins interacting with the corresponding silencer elements. Previous deletion analysis of the 5Ј-flanking region of the human GnRHR gene has revealed a very powerful NRE located between nt Ϫ1017 and Ϫ771. Nevertheless, the functional significance of this NRE is unknown. In the present study, four different cell lines, including the SVOG-4m, OVCAR-3, JEG-3, and ␣T3-1 cells, which express the GnRHR gene, were used as model systems to identify the DNA motif(s) and its interacting transcription factor(s) that mediate the silencing activity of the NRE. The ability of the NRE to completely abolish the activity of a heterologous TK promoter and silence the homologous promoter in a position-independent manner suggests that the element can function as a transcriptional silencer. However, unlike other classical silencers, the action of the NRE appears to be orientation dependent because no significant change of TK promoter activity was observed when the NRE was cloned in the opposite direction.
In addition, the NRE also demonstrated some degrees of promoter-dependence because there was about 25% reduction of homologous promoter activity even when the NRE was placed in the opposite direction. To date, only a small numbers of silencers have been described as orientation dependent (15) (16) (17) , and their functional significance is still unclear. One possible mechanism for the functioning of this kind of silencers is that these elements present their specific binding factors in a particular position or direction relative to other regulatory sequences or factors. For instance, DNA bending as a result of silencer complex binding has been shown to repress gene transcription by physically hindering upstream elements (18) . Therefore, it is possible that inversion of the silencer element can produce a bend in the opposite direction, thus eliminating the steric hindrance of the upstream enhancer elements. Because the NRE works ubiquitously and independent of its position, it is reasonable to believe that this element may functionally interact with different cell-specific GnRHR promoters (or enhancers) to tightly regulate the transcription of the GnRHR gene.
Progressive deletion analysis revealed that most of the silencing activity of the NRE resided in a 9-bp sequence (AAGCAAACT) located at the distal end of the NRE. This sequence shares high level of identity with the consensus octamer regulatory element (ATGCAAAT). Antibody supershift assay and Southwestern blot analysis confirmed that the repressor protein binding to this element was the widely expressed transcription factor Oct-1. More importantly, mutation of this motif into the octamer sequence of the rodent GnRHR promoter did not attenuate its silencing activity, indicating that the repressive role of this octamer sequence is evolutionarily conserved. In fact, the role of Oct-1 as a transcriptional repressor has been well studied in promoters of thyrotropin ␤ subunit gene (19) , pituitary-specific transcription factor pit1/ghf1 gene (20) , von Willebrand factor gene (21) , and B cell-specific B29 (Ig␤) gene (22) , and Kim et al. (19) showed that the silencing activity of Oct-1 resided in its alanine-rich C-terminal domain.
In our present study, the octamer binding sequence was found to repress the GnRHR promoter activity in a wide variety of cell types, a phenomenon that could be explained by the ubiquitous expression of the Oct-1 protein. However, Oct-1 has also been shown to participate in tissue-specific expression of the human GnRHR gene via cooperation with other transcription factors. For instance, a previous study from our laboratory revealed that Oct-1 bound to an AT-rich octamer sequence (5ЈATTTGTAT3Ј) located within the upstream placenta-specific human GnRHR promoter, and it functioned as a transcriptional activator because mutation of this AT-rich sequence reduced the promoter activity drastically (7). However, Oct-1 regulated this placenta-specific gene expression of the GnRHR via cooperation with other transcription factors including cAMP-responsive elementbinding protein, GATA-2, GATA-3, and activating protein-1.
On the other hand, we recently found that there was a possible cross-talk between Oct-1 and a putative C/EBP motif, which cooperated synergistically with a GATA and another C/EBP motif to specifically regulate GnRHR gene transcription in human granulosa-lutein cells (8) . Another important information obtained from these studies is that Oct-1 possesses dual transcriptional functions (both activators and repressors) in regulating human GnRHR gene transcription. These observations may be explained by the fact that Oct-1 can adopt different conformations, depending on the precise nature of the binding and flanking sequences, which in turn determines its transcriptional functions (23) . Indeed, our present mutational analysis showed that alteration of the octamer sequence into the consensus Oct-1 binding motif alleviated its repressive effect on the GnRHR promoter ( Fig.  5) , further supporting the notion that the exact identity of the Oct-1-binding sequence is a critical determinant of its transcriptional activity. The mechanisms by which Oct-1 mediates its activator function have been well documented, and it has been proven that Oct-1 activates transcription by directly interacting with other transcription factors including TATA binding protein, transcription factor IIB, high mobility group protein 2, and Oct-binding factor 1 (24 -29) . Although a recent study has shown that Oct-1 physically interacts with the silencing mediator of retinoid and thyroid receptors to mediate its repressor function (30), the exact mechanisms by which Oct-1 mediates its repressor function on the GnRHR promoter remain to be elucidated. However, the fact that Oct-1 has the ability to bend DNA through its POU S domain (31) may help explain the orientation-dependence for the proper functioning of the NRE. Therefore, mutation of the AAGC subsite of the octamer regulatory sequence may impair the DNA-bending ability of the POUs domain and thus account for the partial elimination of the silencing activity mediated by Oct-1 (Fig. 5) .
Interestingly, a recent report from Belsham and Mellon (32) demonstrated that Oct-1 was one of the downstream transcriptional regulators of the glutamate/nitric oxide/ cyclic-guanosine 5Ј-monophosphate signal transduction pathway because treatment with a nitric oxide donor increased the DNA-binding affinity of Oct-1 to its target site, and this enhanced binding affinity was likely due to increased phosphorylation of Oct-1 by cGMP-dependent protein kinase. This finding is in agreement with previous reports (33, 34) demonstrating that the DNA-binding specificity of Oct-1 could be regulated by different kinases in vitro. These studies implicate that Oct-1-regulated-gene expression can possibly be under the influence of various intracellular signal transduction pathways, which control the phosphorylation status and thus the binding activity of Oct-1. In addition, the transcriptional function of Oct-1 has also been shown to be regulated by nuclear receptors (35) (36) (37) , and of particular interest, Kutoh et al. (37) showed that the glucocorticoid receptor could inhibit Oct-1 function by a mechanism involving direct protein-protein interaction in a hormone-dependent manner. This functional interference between Oct-1 and the glucocorticoid receptor thus represents a novel mechanism by which Oct-1 cross-couples with the nuclear receptor signal transduction pathway. These findings implicate that Oct-1-regulated GnRHR gene transcription may be influenced by a variety of extracellular stimuli and depend on the physiological status of the cell.
EMSA studies revealed that an additional DNA-protein complex (complex-B) was formed merely with nuclear extracts from the gonadotrope-derived ␣T3-1 cells (Fig. 6A) . Both competitive EMSA and antibody supershift assays indicated that Oct-1 was not likely the transcription factor present in this complex (Fig. 6, C and D) . Because this complex was not observed from nuclear extracts of reproductive cell types, we speculated that the transcription factor(s) present in complex-B may be gonadotrope specific. However, we failed to detect additional bands in Southwestern blot analysis of nuclear extracts from ␣T3-1 cells. The significance of these factors in the transcriptional repression of the GnRHR gene demands further investigation, and we cannot exclude the possible existence of a different (or additional) negative regulatory mechanism to control the GnRHR gene expression in the gonadotropes.
In summary, we have identified an octamer regulatory sequence as a core cis-acting silencing element within the human GnRHR 5Ј-flanking region and revealed for the first time that the POU domain transcription factor Oct-1, via binding to this octamer sequence, played a role in the transcriptional repression of the GnRHR gene.
